ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update

被引：0

作者：

Palfi, Stephane ^{[1
,3
]}

Watts, Collin ^{[4
]}

Marc, Gurruchaga Jean ^{[3
]}

Peter, Buttery ^{[4
]}

Scott, Ralph ^{[2
]}

Sarah, Deeley ^{[2
]}

Helene, Lepetit ^{[3
]}

James, Miskin ^{[2
]}

Hiro, Iwamuro ^{[3
]}

Sonia, Lavisse ^{[1
]}

Aurelie, Kas ^{[1
]}

Laure, Ramelli Anne ^{[3
]}

Naoki, Tani ^{[3
]}

Gilles, Fenelon ^{[3
]}

Pierre, Brugie're ^{[3
]}

Stuart, Naylor ^{[2
]}

Philippe, Hantraye ^{[1
]}

Philippe, Remy ^{[1
,3
]}

Roger, Barker ^{[4
]}

Kyriacos, Mitrophanous ^{[2
]}

机构：

[1] CEA I2BM MirCen, Fontenay Aux Roses, France

[2] Oxford Biomed Ltd, Oxford, England

[3] Hop Henri Mondor, APHP, F-94010 Creteil, France

[4] Cambridge Ctr Brain Repair, Cambridge, England

来源：

HUMAN GENE THERAPY | 2012年 / 23卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：A61 / A61

页数：1

共 50 条

[31] Efficacy of electroconvulsive therapy in Parkinson's disease: A clinical trial
Afshari, Daryoush
Shakeri, Jalal
Khodamoradi, Mehdi
Abadi, Reza Nejad Shahrokh
Rahkan, Jaza
Hezarkhani, Leila Afshar
NEUROSCIENCE LETTERS, 2022, 772
[32] Gene Therapy for Pain: Results of a Phase I Clinical Trial
Fink, David J.
Wechuck, James
Mata, Marina
Glorioso, Joseph C.
Goss, James
Krisky, David
Wolfe, Darren
ANNALS OF NEUROLOGY, 2011, 70 (02) : 207 - 212
[33] Prevalence, clinical features and treatment of depression in Parkinson's disease: An update
Omar ME Abdel-Salam
World Journal of Neurology, 2015, 5 (01) : 17 - 38
[34] An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
Hussaini Adam
Subash C. B. Gopinath
M. K. Md Arshad
Tijjani Adam
N. A. Parmin
Irzaman Husein
Uda Hashim
3 Biotech, 2023, 13
[35] An update on pathogenesis and clinical scenario for Parkinson's disease: diagnosis and treatment
Adam, Hussaini
Gopinath, Subash C. B.
Arshad, M. K. Md
Adam, Tijjani
Parmin, N. A.
Husein, Irzaman
Hashim, Uda
3 BIOTECH, 2023, 13 (05)
[36] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update
McFarthing, Kevin
Buff, Sue
Rafaloff, Gary
Pitzer, Kenneth
Fiske, Brian
Navangul, Anaya
Beissert, Katelyn
Pilcicka, Aleksandra
Fuest, Rosie
Wyse, Richard K.
Stott, Simon R. W.
JOURNAL OF PARKINSONS DISEASE, 2024, 14 (05) : 899 - 912
[37] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
McFarthing, Kevin
Rafaloff, Gary
Baptista, Marco A. S.
Wyse, Richard K.
Stott, Simon R. W.
JOURNAL OF PARKINSONS DISEASE, 2021, 11 (03) : 891 - 903
[38] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
McFarthing, Kevin
Buff, Susan
Rafaloff, Gary
Fiske, Brian
Mursaleen, Leah
Fuest, Rosie
Wyse, Richard K.
Stott, Simon R. W.
JOURNAL OF PARKINSONS DISEASE, 2023, 13 (04) : 427 - 439
[39] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
McFarthing, Kevin
Rafaloff, Gary
Baptista, Marco
Mursaleen, Leah
Fuest, Rosie
Wyse, Richard K.
Stott, Simon R. W.
JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1073 - 1082
[40] Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
Valdes, Pamela
Schneider, Bernard L.
FRONTIERS IN NEUROANATOMY, 2016, 10

← 1 2 3 4 5 →